Navigation Links
ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
Date:5/17/2010

LEUVEN, Belgium and LUND, Sweden, May 17, 2010 /PRNewswire-FirstCall/ --

- Trial to Study Patients with Colorectal and Ovarian Cancer

ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (OMXS: BINV) announce today that their partner Roche (SIX: RO, ROG; OTCQX: RHHBY) will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancers. ThromboGenics and co-development partner BioInvent will receive a milestone payment of EUR10 million from Roche under the terms of the strategic alliance agreement signed in June 2008. ThromboGenics, which discovered TB-403, receives 60% and BioInvent 40% of all revenue from the alliance with Roche for this anti-cancer antibody.

This trial is a multi-centre, open-label (monotherapy), dose-finding study with intravenous TB-403. The primary objective of the study will be to establish the TB-403 concentration-pharmacodynamic (PD) effect relationship using DCE-MRI (dynamic contrast-enhanced magnetic resonance imaging) and to identify the minimally PD effective dose. The trial will recruit up to 50 patients across three European sites.

With the start of this study, Roche will assume responsibility for all future development of TB-403, continuing the work started by ThromboGenics and BioInvent. A Joint Steering Committee made up of representatives from Roche, ThromboGenics and BioInvent will continue to oversee research and development activities. In addition, Roche will continue to provide funding to ThromboGenics and BioInvent for re
'/>"/>

SOURCE ThromboGenics NV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
4. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
5. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
6. ThromboGenics Microplasmin Phase III Program Progressing According to Schedule
7. ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
8. ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
9. ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402)
10. ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
11. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015  Spring Bank Pharmaceuticals, Inc., a ... treatment of virus infections, today announced that ... Vice President of Finance, a newly created role. ... administrative activities, including financial planning and reporting, accounting ... J. Jensen , President and CEO. ...
(Date:2/26/2015)... 2015 Vectorious Medical Technologies, ... system for patients suffering from congestive heart failure ... $5 million financing round. Investors in the round ... by Yehuda Zisapel and Prof. Nava Zisapel ... Muntzer and others; and the U.S.-based Global Cardiovascular ...
(Date:2/26/2015)... Surna Inc. (OTCQB: SRNA), an engineering, ... cannabis cultivation technology, announced today senior leadership changes ... manufacturing and engineering company. Surna announced ... CEO, will be stepping down on April 15 ... team has accomplished thus far and grateful I ...
Breaking Medicine Technology:Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2Vectorious Medical Technologies Completes $5M Raise 2Surna, Inc. Announces Senior Leadership Changes 2Surna, Inc. Announces Senior Leadership Changes 3Surna, Inc. Announces Senior Leadership Changes 4
(Date:2/26/2015)... Atlanta, GA (PRWEB) February 26, 2015 ... 2015 Movers & Makers Awards finalist. ... of exceptional companies involved in the manufacturing, processing, or distribution ... at the Gwinnett Center. This annual event serves as ... companies and is expected to draw more than 300 local ...
(Date:2/26/2015)... DC (PRWEB) February 26, 2015 ... Dual-Eligibles Initiatives: What’s Working? What’s Not? What’s New? ... Medicare-Medicaid dual-eligibles programs to achieve strong outcomes for ... has been happening in the implementation phase of ... have been made? Which ones need to be ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 The hip ... local pastor and Central Texas resident John Short to resume ... he has set out to climb Mt. Kilimanjaro, the highest ... stop human trafficking. , Starting in his late 20s, Short ... eventually his hip bones and sockets were bone on bone. ...
(Date:2/26/2015)... February 26, 2015 Kantar Health ... The Sunday Times “100 Best Small Companies to Work For” ... UK has been included on the list, which measures employees’ ... fantastic team here at Kantar Health UK, and we are ... Kantar Health UK CFO Mark Hinton-Jones said. “The team is ...
(Date:2/26/2015)... Today, Highmark Health announced that longtime board ... down as chairman of the board of directors and ... chairman of The PNC Financial Services Group, Inc. and ... Health President and Chief Executive Officer David L. Holmberg ... of Highmark Inc.; both changes are effective as of ...
Breaking Medicine News(10 mins):Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3Health News:Upcoming AIS Virtual Conference Will Explain What Is and Is Not Working in Medicare-Medicaid Dual Eligibles Programs 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Kantar Health UK Named One of The Sunday Times 100 Best Small Companies to Work For 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 2Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 3Health News:Highmark Health Appoints Joseph C. Guyaux Chairman of the Board of Directors 4
... Sept. 27 The Philadelphia AIDS,Consortium is launching ... of the Corporation of National and Community Service ... service program targets,people living with HIV/AIDS to help ... medical and support services for those,infected and affected ...
... who play them, Irish researchers say , , THURSDAY, Sept. 27 (HealthDay ... the lungs, it is music to the ears. , A smoking ... as well as the health of musical instruments -- such as ... , "Research to date looking at the health effects of the ...
... Based on Favoritism, WASHINGTON, Sept. 27 ... to urge the giant medical,supplies distribution company ... to help AmerisourceBergen become one of the ... Waving informational picket signs saying "Just ...
... Boulder, CO, October 1, 2007 NeuroMark, a Boulder, ... genetic test to identify people at risk of suicidal ... The test, called the Mark-C test, is expected to ... to reduce a recently announced spike in suicide rates ...
... (Nasdaq:,NUVA), a medical device company focused on developing products ... relating to its third quarter 2007 earnings announcement, which,will ... close of the,market. NuVasive will hold a conference ... / 4:00 p.m. CT to discuss the results. The ...
... Inc. (NYSE:,CVD) today announced that it has elected ... Dr. Costley adds further executive management experience ... extensive scientific depth in nutritional,chemistry, food safety and ... Officer of International Multifoods Corporation,manufacturer of branded consumer ...
Cached Medicine News:Health News:TPAC's AmeriCorps Program Launches 7th Year In Action 2Health News:Accordions Breathe Easier Since Smoking Ban 2Health News:AmerisourceBergen Workers Rally For Better Working Conditions 2Health News:Genetic test announced for suicidal ideation in patients using antidepressant drugs 2Health News:Genetic test announced for suicidal ideation in patients using antidepressant drugs 3Health News:Genetic test announced for suicidal ideation in patients using antidepressant drugs 4Health News:Genetic test announced for suicidal ideation in patients using antidepressant drugs 5Health News:NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results 2Health News:NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results 3Health News:Covance Elects Dr. Gary E. Costley to Board of Directors 2
Compact tray features all components for urethral catheterization....
... first time, the Integrated Cytometry Solution ... post-analytical solution coupled with complete LIS ... steps a sample undergoes - and ... one - it delivers a progressive ...
Convective Air Warming Blankets...
MAMMOMAT 3000 Nova supports high-volume screening as well as interventional diagnostics. Versatile procedural capabilities include magnification, stereotactic biopsy, needle localization, and specime...
Medicine Products: